Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Nanoparticles improve drug delivery and effectiveness in treating inflamed skin.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Nephronectin is linked to worse breast cancer outcomes and helps cancer spread.

The treatment helped some patients with severe hair loss regrow hair.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Combining 5% minoxidil and 0.5% anthralin can help regrow hair in some severe alopecia areata patients.

Topical contact sensitizers can treat certain skin conditions by changing the immune response.

New cancer drugs often cause skin and nail problems.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Prostaglandin E2 promotes skin cancer, but certain supplements and drugs may help reduce risk and improve treatment.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

HDR electronic brachytherapy effectively treats nonmelanoma skin cancer with good cosmetic results and minimal side effects.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

Deucravacitinib helped a man regrow hair and improve psoriasis.